Biotechnology

Filter

Current filters:

None

Popular Filters

90 to 114 of 2219 results

AFFiRiS reports breakthrough in Alzheimer's disease with AD04

AFFiRiS reports breakthrough in Alzheimer's disease with AD04

05-06-2014

Austrian biotech firm AFFiRiS has released Phase II results with its proprietary AD04 vaccine, saying…

AD04AFFiRiSBiotechnologyGlaxoSmithKlineNeurologicalResearch

Kymab strengthens management team with two senior appointments

Kymab strengthens management team with two senior appointments

03-06-2014

UK-based monoclonal antibody biopharmaceutical company Kymab has announced the appointment of Steve Arkinstall…

BiotechnologyBoardroomKymabPharmaceuticalUK

Biota Pharma plans restructuring following loss of BARDA contract

02-06-2014

USA-based Biota Pharmaceuticals has adopted a plan to restructure the company's operations following…

Anti-viralsBiota PharmaceuticalsBiotechnologyFinanciallaninamivirManagementUSA

GlaxoSmithKline surprises with mega-dollar deal for cancer program

GlaxoSmithKline surprises with mega-dollar deal for cancer program

02-06-2014

UK biotech firm Adaptimmune revealed this morning that it has entered into a collaboration and licensing…

AdaptimmuneBiotechnologyGlaxoSmithKlineLicensingOncologyResearch

ASCO 2014 kicks off with news on lenvatinib, Cyramza, olaparib and Recentin

ASCO 2014 kicks off with news on lenvatinib, Cyramza, olaparib and Recentin

01-06-2014

The 2014 Annual Meeting of the American Society of Clinical Oncology (ASCO) began on Friday in Chicago,…

AstraZenecaBiotechnologyCyramzaEisaiEli LillylenvatinibolaparibOncologyRecentinResearch

US FDA accepts resubmission of Lemtrada sBLA by Genzyme

US FDA accepts resubmission of Lemtrada sBLA by Genzyme

30-05-2014

French drug major Sanofi (Euronext: SAN) and its subsidiary Genzyme said today that the US Food and Drug…

BiotechnologyGenzymeLemtradaNeurologicalRegulationSanofiUSA

Summit appoints Leopoldo Zambeletti as Non-Executive Director

Summit appoints Leopoldo Zambeletti as Non-Executive Director

30-05-2014

UK-based drug discovery and development company Summit has announced the appointment of Leopoldo Zambeletti…

BiotechnologyBoardroomSummit PharmaceuticalsUK

Cell Therapeutics changes name to CTI BioPharma

Cell Therapeutics changes name to CTI BioPharma

30-05-2014

US biotech firm Cell Therapeutics Inc says it will change its corporate name to CTI BioPharma Corp effective…

BiotechnologyCell TherapeuticsFinancial

Array BioPharma inks deal with Biogen Idec on autoimmune disorders

Array BioPharma inks deal with Biogen Idec on autoimmune disorders

30-05-2014

US biotech firms Array BioPharma and Biogen Idec have entered into a collaboration for the discovery…

Array BioPharmaBiogen IdecBiotechnologyImmunologicalsLicensingResearch

uniQure signs up Medison to distribute Glybera in Israel

uniQure signs up Medison to distribute Glybera in Israel

29-05-2014

Netherlands-based human gene therapy firm uniQure has entered an exclusive distribution agreement with…

BiotechnologyGlyberaLicensingMedison PharmaRare diseasesRest of the WorlduniQure

BioTime's subsidiary Asterias settles patent interference proceedings with ViaCyte

29-05-2014

US biotech firm BioTime says its subsidiary Asterias Biotherapeutics has entered into a settlement agreement…

Asterias BiotherapeuticsBiotechnologyBioTimeLegalPatentsUSAViaCyte

High level of innovation seen in psoriasis treatment pipeline

High level of innovation seen in psoriasis treatment pipeline

29-05-2014

Despite mostly targeting established molecules, the psoriasis pipeline is showing a high level of innovation…

BiotechnologyBiotest AGDermatologicalsInflammatory diseasesResearchtregalizumab

Joint position to grow Australia's biopharmaceutical industry

Joint position to grow Australia's biopharmaceutical industry

29-05-2014

Trade groups AusBiotech and Medicines Australia this morning published a joint statement sent to the…

AustraliaBiotechnologyFinancialMarkets & MarketingPatentsPharmaceuticalResearch

Genzyme gains UK NICE backing for second MS drug Lemtrada

Genzyme gains UK NICE backing for second MS drug Lemtrada

28-05-2014

The UK drugs watchdog the National Institute for Health and Care Excellence (NICE) has issued final guidance…

AubagioBiotechnologyGenzymeLemtradaNeurologicalPricingRegulationSanofiUK

AusBiotech makes submission on tax impediments for small business

AusBiotech makes submission on tax impediments for small business

28-05-2014

Trade group AusBiotech has made a submission to the Australian Board of Taxation, which is conducting…

AustraliaBiotechnologyFinancialResearch

Executive Q&A: Paul Higham, CEO of immatics

Executive Q&A: Paul Higham, CEO of immatics

27-05-2014

In an interview with The Pharma Letter, immatics chief executive Paul Higham discusses the company's…

BiotechnologyCancerGermanyHealth Medical Pharmaimmatics biotechnologiesImmunologyInterviewsMedicineOncologyVaccination

90 to 114 of 2219 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top